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Tutkimuksen tavoitteena on tarkastella Suomessa terveyskeskusvastaanotolla käyneiden potilaiden 
ICPC-2 -luokiteltuja hoitoepisodeja, niihin liittyvää resurssien käyttöä ja niistä aiheutuvia 
terveydenhuollon suoria kustannuksia.  
 
Tutkimus on prospektiivinen monitorointitutkimus liittyen Vaikuttava Terveysasema -hankkeeseen. 
622 potilasta rekrytoitiin tutkimukseen kolmelta eri terveysasemalta Pirkanmaalta 
vastaanottokäynnin yhteydessä yhden viikon aikana vuonna 2011. Potilaille laadittiin 
kyselylomakkeet, joissa tiedusteltiin mm. sosioekonomisia tietoja, koettua terveydentilaa ja 
toimintakykyä, sekä arviota hoidon vaikuttavuudesta.  
 
Tutkimuspotilaiden perusterveydenhuollon ja erikoissairaanhoidon resurssien käyttö selvitettiin 
kolmen kuukauden ajalta potilastietojärjestelmästä. Resurssien käyttö arvotettiin palvelun tuottajan 
vuoden 2012 kustannuksilla.  
 
Keskimäärin yhdellä potilaalla oli kolmen kuukauden seuranta-ajalla 1,22 hoitoepisodia. Potilaiden 
ominaisuudet ja resurssien käyttö erosivat ryhmien välillä. Suurin episodiryhmä oli ICPC-2 -luku L 
eli ’Tuki- ja liikuntaelinsairaudet’ (17 %). Tavallisin (8 %) yksittäinen episodi oli 
ylähengitystieinfektio. Keskimäärin hoitoepisodi maksoi kolmen kuukauden ajalla 389,56 euroa 
(keskivirhe 61,11) ja mediaani 165,00 euroa (kvartiilivälin pituus 118,46—288,56). Keskimäärin 
kalleimmat (909,85 euroa) hoitoepisodit olivat ICPC-2 -luvussa K eli ’Verenkiertoelimet’. Samassa 
ryhmässä oli myös kallein yksittäinen episodi, jonka hinta oli 32 545,56 euroa. Kallein prosentti 
hoitoepisodeista kattoi yhteensä 36 % hoitoepisodikustannuksista.  
 
Potilaiden ominaisuudet, resurssien käyttö ja kustannukset erosivat ICPC-2 -lukujen välillä, mikä 
voitaisiin ottaa huomioon suunnitellessa palveluiden tuottamista ja hinnoittelua. Tulevaisuuden 
tutkimuksiin tulisi saada tarkemmat diagnoosit, isompi aineisto ja pidemmät seuranta-ajat.  
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Key points 
 
Patient characteristics, resource use and costs related to different episodes of care based on the 
ICPC-2 classification have not been published. 
 
The most common episodes were in the “Musculoskeletal” chapter, but the highest mean and 
single-episode costs were related to the “Circulatory” chapter. 
 
The mean (median) cost of episodes that started in primary care was €390 (€165) during the three-
month follow-up. 
 
Patient characteristics, resource use and costs differed significantly between the ICPC-2 chapters. 
The most expensive one percent of the episodes covered 36% of the total costs of all the episodes.   
3 
 
Introduction 
An episode of care (EOC) in primary health care (PHC) is defined as a health problem needing 
testing, diagnosis, care or follow-up from its first presentation by the patient to a family doctor, 
nurse or acute policlinic until completion of the last health care (HC) contact related to it [1]. 
An EOC differs from an episode of disease—a health problem from its onset through its 
resolution—and also from an episode of illness, i.e. a period during which a person suffers from 
symptoms [2]. The cost of an episode (COE), disease, illness or care should be differentiated, 
because they apply to different populations and have different contents. 
An EOC is the appropriate unit for assessing important attributes of PHC such as continuity, 
coordination, outcomes and satisfaction [3]. An EOC can be defined with an International 
Classification of Primary Care (ICPC) episode title code [1]. The ICPC was developed by the 
Wonca (World Organization of Family Doctors) International Classification Committee and 
designed to describe the three basic elements of an EOC in publicly funded HC: reason for 
encounter (RFE), diagnostic label, and diagnostic and therapeutic intervention [4][5][6]. The last 
diagnosis made (i.e. diagnostic label) during an EOC is the current episode title [1], which may vary 
over time. It should not be confused with the RFE, an agreed statement of the reason(s) why a 
person enters the HC system. [1][7][8][9] 
Due to comorbidity, different episodes frequently exist at the same time [2]. Okkes and colleagues 
noticed that differences in the annual number of EOCs and encounters per patient were small 
between countries. However, there were large differences in resource consumption per EOC. The 
most prominent differences were related to prescriptions of antibiotics, oral contraceptives and 
cardiovascular medication, and treatment of gastrointestinal tract complaints. [12] These together 
with international price differences (unit costs) in HC services can cause large differences in the 
COEs between countries and demonstrate the importance of national COE evaluations.  
There are no previous publications dealing with ICPC-2-based EOCs in Finland. COEs are 
relatively unknown in Finland and elsewhere. Due to limited resources, and for the purposes of 
health economic evaluation, the types of EOCs appearing in PHC and related resource consumption 
and costs are becoming important. The lack of published knowledge related to PHC resources has 
been noticed in Finnish studies [13][14][15][16][17][18][19][20][21][22]. However, just a few 
Finnish studies have assessed disease-based PHC costs based on relatively comprehensive data 
[13][23][22][24], and usually with a focus on a single patient group without EOCs. 
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The aim of this study was to explore patient characteristics, resource use and costs related to 
different ICPC-2-based EOCs in the Finnish PHC setting during a three-month time period.  
 
Material and methods  
The Effective Health Centre (EHC) study (funding from the Pirkanmaa Hospital District) was a 
prospective three-month follow-up study (sc. institutional study) carried out during 2011 in three 
different PHC practices in Pirkanmaa, Finland [25]. The study sought to recruit as many patients as 
possible during a one-week period in each practice. Patients with an appointment with a nurse or a 
doctor on the recruiting day were included, and patients visiting a specialized health guidance clinic 
for pregnant women, children and mothers were excluded. The recruitment date was the starting 
point (index day) for a three-month follow-up period of EOCs. 
In total, 622 patients and 32 doctors participated in the EHC study. The study sample includes 41% 
(622/1520) of all the patients who had an appointment in the study practices during the recruitment 
phase. [25]  
The patient- and HC-personnel-reported data were collected using tailored questionnaires. If they 
agreed to participate, the patients filled in a questionnaire given by a research assistant before or 
after their appointment. In addition, data were collected with patient consent from an electronic 
health record (EHR). 
The EOCs were divided into main groups (A, B, D, etc.) based on the ICPC-2 chapter title codes. 
The episodes were labelled with the last diagnosis made during the three-month EOC, which was 
the EOC class used in the analysis. [1] Resource use (visits in PHC and secondary health care 
(SHC), examinations, laboratory tests, referrals, treatments and hospitalizations) (Table III) was 
collected from an EHR retrospectively by two researcher physicians who read the patient EHRs 
from the three-month follow-up period. The resources are presented as means together with their 
standard errors (SE), because the mean is the expected value of distribution [26]. 
Resource costing was done from the perspective of the HC payer, and the COEs include only direct 
HC costs. Unit costs were based on the official Pirkanmaa health district, Tampere health centre and 
Fimlab laboratory list prices (tariffs) from 2013 (Supplementary Appendix I available online). The 
data were checked for general consistency and any illogical results were checked and corrected. The 
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ICPC-2-based costs were bootstrapped [14] to establish robust confidence intervals for skewed 
distributions. SPSS V20 and Stata V10 statistical software were used in the data analysis. 
Study permission was granted by the research committee of the City of Tampere and the chief 
physician of one clinic not located in Tampere. Due to the nature of this study, there was no need to 
apply for permission from the hospital district’s ethics committee. 
 
Results 
EOCs were determined for 99% (618/622) of the study patients. The patients were typical Finnish 
HC patients regarding their age, occupational status and chronic diseases (table 1). The mean age 
was 49 years (median 55.0, interquartile range IQR 27.0–69.5). A long-term disease was the RFE 
for 31% (193) of the patients.  
The 618 patients had 752 EOCs altogether. On average, the patients had 1.22 EOCs. The number of 
EOCs divided into ICPC-2 chapters is presented in Figure 1. The greatest number of EOCs (130) 
was in the “Musculoskeletal” chapter. The most common (63) single EOC was “upper respiratory 
infection”. 
According to a doctor’s or nurse’s judgment, the phase of the primary EOC on the recruiting day 
was labelled as a “new episode” for 52% (326) of the patients that presented to HC for the first time 
for this new health problem, and the rest of the episodes were labelled as a “pre-existing episode” 
presenting with a problem that had required HC previously. Altogether 40% (304) of the EOCs 
continued after the follow-up period. Table II shows the patients’ characteristics by EOC chapter. 
Table III lists the resources used to calculate mean and total costs of the EOCs. The mean cost of 
the EOCs was €389.56 (SE 61.11) and the median was €165.00 (IQR €118.46–288.56) during the 
three-month follow-up. The mean costs and 95% confidence intervals by EOC chapter are presented 
in Figure 2. The most expensive group, on average, was “Circulatory”. The mean cost of PHC per 
episode was €237.21. The exact costs and arithmetic confidence intervals are available 
(Supplementary Appendix II available online). 
The most expensive one percent of the EOCs covered 36% (€105,787.45 / €293,335.73) of the total 
costs in the data. The most expensive single episode was in the “Circulatory” chapter: €32,545.56. 
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Discussion 
Considerable differences were found in patient characteristics, resource use and costs related to 
different EOCs. The most expensive one percent of the EOCs covered 36% of the total costs, which 
can be of interest to the Finnish municipal payer of HC services. The highest number of episodes 
was “Musculoskeletal”. However, the highest mean and single-episode costs were related to chapter 
K, “Circulatory”. The dual source of costs (PHC and SHC) is an important cause of variation. 
The benefits of this study are the precise time during which the data were collected, the amount of 
exact information collected from the EHR together with the patient- and clinician-reported data and 
the use of valid unit cost data. By these methods it was possible to obtain accurate descriptive costs 
based on the ICPC-2 EOC titles. For example, some register studies ignore the exact data coverage 
time, i.e. some of the patients are lost during the follow-up. 
However, this study had some limitations. First, the data collection period was limited to three 
months. An EOC is a longitudinal concept and this study may be regarded as cross-sectional when 
considering long-term EOCs. Since the time frame was relatively short, there was a residual risk 
that some EOC follow-ups were censored. However, this study was initially targeted to assess the 
short-term cost-effectiveness of different types of PHC service production systems. A longer 
follow-up period or a larger data set was not feasible due to the accurate and detailed data collection 
required and the lack of data collection resources and EHR data. Furthermore, a three-month 
follow-up can be suitable for capturing the costs of most acute short-term EOCs and also the acute 
phase of long-term EOCs. 
Second, the data were collected in the beginning of the year when respiratory infections are 
overrepresented, which however should not bias the resource use or mean costs of the EOC chapter. 
The problem related to changes in the patient material can be corrected in the future by choosing a 
one-year follow-up period and follow-ups with a predefined patient entering-exiting timeline [22]. 
Third, all the episodes did not last the entire follow-up period. However, they did not restart, and 
most acute conditions resolve within three months. Thus, the resource and cost data are valid for the 
expected three-month timeline. This should be accounted for when the results are interpreted or 
when resource use is extrapolated. 
Fourth, the recruiting method prevented full coverage of all available patients. Despite this, 41% of 
the patients participated, which is acceptable coverage for a study including patient- and clinician-
reported data. Furthermore, due to patient-reported outcomes, written consent was needed. This 
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may have caused some selection bias, where some patient groups systematically dropped out. 
Unfortunately, ICPC-2 codes of the RFEs were not coded systematically into the EHR in the study 
health centres at the time of the study. However, in 2014 documenting of the RFEs had increased 
into 66 % in the study health stations at Tampere. The top 4 RFEs in 2014 were upper respiratory 
tract infection, high blood pressure, back pain and diabetes. There was no obvious bias in the study 
sample regarding the RFEs. 
Fifth, the data were recorded manually, and local unit costs were collected from a few sources due 
to a lack of a single unit cost source. However, national unit costs can underestimate (local) costs; 
indexing to the present value does not seem to handle the problem very well, and local costs can be 
more precise for a particular resource [21][22]. For this reason, and also due to a lack of unit costs 
for many resources, a national unit cost list was not used as the key unit cost source. 
Lastly, the targeted analytical perspective was HC payers. However, in practice the perspective was 
limited to the HC service provider’s perspective, with most costs being the provider’s tariffs. Drug 
costs (mostly paid by the social insurance institution) were excluded due to limitations in their 
reporting, a lack of reimbursement data and the probable small impact on total EOC costs. 
Furthermore, travel costs and production losses (presenteeism, absenteeism) would have been 
important for a societal perspective, but sick-leave data were not collected. 
When considering the generalizability and applicability of the results, earlier studies were reviewed. 
Based on the current study, a patient is likely to visit his doctor around 4–5 times per year. Based on 
a UK study, a patient visits his doctor an average of 5.3 times per year [27] and is likely to present 
with three to four symptoms at the same encounter [28]. Soler and colleagues studied the prevalence 
and incidence of RFEs and EOCs in three countries. They discovered that RFEs seem to be more 
consistently distributed between populations than EOCs [1], i.e. symptoms are distributed equally 
but care is not. Furthermore, the relationship between RFE and diagnostic label is very similar 
regardless of the country [29], with some differences in the size ranges of the relationships [30]. 
Consequently, the results of this study may be applicable to a wider setting from the perspective of 
visit frequency/resource consumption. 
The practical implication of the results for a clinician, a health economist or decision-makers is that 
they describe the spectrum of EOCs in PHC and show how resources and costs are distributed 
between different types of EOCs and what patient characteristics are in a particular ICPC-2 chapter. 
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Finally, based on the experience gained from this study, further studies should include more specific 
diagnoses, extended follow-up times and larger data sets. Automatic EHR data collection may solve 
these challenges. 
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Legends  
 
Table I. Patient characteristics of the included patients (N 618: patients with an episode of care). 
Proportion is counted from the available data. 
 
Table II. Episode characteristics. The episodes are represented through the patients they include. 
Notice that a patient may belong to several episodes (range 1–3). Thus, e.g. the mean age of the 
cases in the episodes does not match up to the mean age of the patients. 
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Table III. Means and standard errors (in parentheses) of the resources. The number of episodes in 
each chapter is shown in Table II. 
*Includes visits to a physiotherapist, dietician, foot therapist and mental health worker. 
** Includes radiography, ultrasonography and MRI. 
*** Includes e.g. spirometry, tolerance test, Holter monitoring and scopies.  
****Includes visits to the hospital emergency room, a dispensary outpatient clinic and a specialist. 
 
Figure 1. The number of episodes of care divided into ICPC-2 chapters. 
 
Figure 2. Mean costs and their 95% bootstrapped confidence intervals related to ICPC-2 chapters. 
Bootstrapping is a resampling technique used to mimic the “true” distribution where the sample was 
collected.  
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Table I 
Characteristic   
Gender, n (%): 618   
  Female 381 (62)  
Age (mean age 48.60 years, standard error 0.98), n (%): 617  
  < 30 162 (26)  
  30–64  244 (39)  
  > 64 211 (34)  
Housing, n (%): 538  
  With a partner 247 (46)  
  With children 25 (5)  
  With a partner and children 66 (12)  
  With others 32 (6)  
  Alone 168 (31)  
Employment, n (%): 538  
  Working full time or part-time 153 (28)  
  Unemployed 66 (12)  
  Retired 262 (49)  
  Other, e.g. student, childcare at home 56 (10)  
Occupation, n (%): 538  
  Employee 262 (49)  
  An entrepreneur 61 (11)  
  An agricultural entrepreneur 4 (1)  
  A lower-level clerical worker 74 (14)  
  An upper-level clerical worker 65 (12)  
  Other 69 (13)  
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Financial situation, n (%): 538  
  Good 96 (18)  
  Fairly good 119 (22)  
  Average 215 (40)  
  Fairly poor  78 (14)  
  Poor 27 (5)  
Chronic disease, n (%): 608  
  At least one 362 (60)  
  Hypertension 170 (28)  
  Osteoarthrosis (hip or knee) 91 (15)  
  Depression 48 (8)  
  Diabetes 70 (12)  
  Asthma or chronic obstructive pulmonary disease 71 (12)  
  Heart disease 88 (14)  
  Cancer 20 (3)  
 
 
  
15 
 
Table II 
ICPC-2 code (n) Mean age 
(standard 
error) 
Female (%) At least one 
emergency 
or other 
urgent visit 
(%) 
At least 
one 
chronic 
disease 
(%) 
A pre-
existing 
episode 
(%) 
A: General and 
Unspecified (53) 
52.6 (3.4) 36 (68)  7 (13) 30 (57) 25 (47) 
B: Blood, Blood 
Forming Organs and 
Immune Mechanism 
(10)  
60.1 (5.6) 7 (70) 0 (0) 7 (70)  5 (50) 
D: Digestive (48) 46.2 (3.6) 32 (67) 8 (17) 30 (63) 15 (31) 
F: Eye (15) 44.6 (6.8) 8 (53) 2 (13) 7 (47) 8 (53) 
H: Ear (45) 36.1 (4.6) 26 (58) 6 (13) 14 (31) 26 (58) 
K: Cardiovascular 
(104) 
66.2 (1.4) 65 (63) 7 (7) 80 (77) 81 (78) 
L: Musculoskeletal 
(130) 
52.3 (1.7) 82 (63) 18 (14) 88 (68) 82 (63) 
N: Neurological (27) 55.1 (4.6) 18 (67) 2 (7) 19 (70) 13 (48) 
P: Psychological 
(38) 
48.0 (3.3) 24 (63) 0 (0) 27 (71) 25 (66) 
R: Respiratory (111) 33.4 (2.2) 68 (61) 23 (20) 45 (41) 36 (32) 
S: Skin (61) 51.4 (2.9) 39 (64) 6 (10) 38 (62) 23 (38) 
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T: 
Endocrine/Metabolic 
and Nutritional (50) 
62.2 (2.3) 25 (50) 0 (0) 43 (86) 43 (86) 
U: Urological (15) 59.5 (4.7) 10 (67) 3 (20) 10 (67) 6 (40) 
W: Pregnancy, 
Childbearing, 
Family Planning (6) 
28.8 (3.4) 6 (100) 0 (0) 3 (50) 1 (17) 
X: Female Genital 
(25) 
48.6 (3.9) 25 (100) 1 (4) 14 (56) 9 (36) 
Y: Male Genital (9) 50.9 (10.5) 0 (0) 0 (0) 5 (56) 5 (56) 
Z: Social Problems 
(6) 
77.8 (5.4) 4 (67) 0 (0) 6 (100) 3 (50) 
All episodes (753) 50.5 (0.9) 475 (63) 83 (11) 466 (62) 406 (54) 
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Table III 
 
Resource Primary care visits Primary care calls Primary 
care 
ward 
Examinations Secondary care 
ICPC-
chapter 
Doctor  Nurse On-call 
doctor 
Other* Doctor  Nurse  Days Labora-
tory tests  
Imaging 
** 
Special 
*** 
 
Visits 
**** 
 
Ward 
days 
Procedures 
A 0.7925 
(0.1122) 
0.8679 
(0.2302) 
0.1698 
(0.0645) 
0.0000 
(0.0000) 
0.4151 
(0.1125) 
0.1132 
(0.0695) 
0.2453 
(0.2453) 
3.1132 
(0.6684) 
0.1509 
(0.0681) 
0.0943 
(0.0487) 
0.0377 
(0.0264) 
0.3585 
(0.3585) 
0.0189  
(0.0189) 
B 0.9000 
(0.1795) 
0.7000 
(0.2603) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.4000 
(0.1633) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
2.8000 
(1.4283) 
0.3000 
(0.2134) 
0.1000 
(0.1000) 
0.1000 
(0.1000) 
0.0000 
(0.0000) 
0.0000  
(0.0000) 
D 1.1042 
(0.1124) 
0.1875 
(0.0643) 
0.2083 
(0.0727) 
0.0000 
(0.0000) 
0.4375 
(0.1070) 
0.2708 
(0.0976) 
0.0000 
(0.0000) 
4.0417 
(0.7372) 
0.1250 
(0.0567) 
0.1250 
(0.0482) 
0.1042 
(0.0536) 
0.0417 
(0.0417) 
0.0417  
(0.0292) 
F 1.1333 
(0.13333) 
0.0667 
(0.0667) 
0.1333 
(0.0909) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.1333 
(0.1333) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.0667 
(0.0667) 
0.2000 
(0.1069) 
0.0000 
(0.0000) 
0.0000  
(0.0000) 
H 0.9778 
(0.1167) 
0.4444 
(0.1033) 
0.2000 
(0.0985) 
0.0000 
(0.0000) 
0.1556 
(0.0546) 
0.0667 
(0.0492) 
0.0000 
(0.0000) 
0.0889 
(0.0429) 
0.0000 
(0.0000) 
0.0667 
(0.0376) 
0.1111 
(0.0571) 
0.0000 
(0.0000) 
0.0222  
(0.0222) 
K 1.2115 
(0.0793) 
0.6154 
(0.1025) 
0.0865 
(0.0338) 
0.0000 
(0.0000) 
0.3558 
(0.0772) 
0.3269 
(0.1698) 
0.1250 
(0.0882) 
4.6538 
(0.5134) 
0.0769 
(0.0296) 
0.0865 
(0.0309) 
0.0481 
(0.0211) 
0.5385 
(0.3811) 
0.0481  
(0.0317) 
L 1.2769 
(0.0927) 
0.2077 
(0.0564) 
0.2154 
(0.0608) 
0.3615 
(0.1048) 
0.4077 
(0.0662) 
0.0462 
(0.0215) 
0.0000 
(0.0000) 
1.1231 
(0.3064) 
0.5154 
(0.0759) 
0.0231 
(0.0132) 
0.1846 
(0.0359) 
0.0000 
(0.0000) 
0.0154  
(0.0108) 
18 
 
N 1.1481 
(0.1158) 
0.1111 
(0.0616) 
0.1111 
(0.0815) 
0.3333 
(0.3333) 
0.3704 
(0.2274) 
0.0741  
(0.0741) 
0.0000 
(0.0000) 
2.2593 
(1.1076) 
0.2963 
(0.1171) 
0.1481 
(0.0697) 
0.2222 
(0.1111) 
0.0000 
(0.0000) 
0.0000  
(0.0000) 
P 1.5000 
(0.1799) 
1.3421 
(0.6189) 
0.0000 
(0.0000) 
0.5000 
(0.2223) 
0.4211 
(0.1443) 
0.1316 
(0.0858) 
0.0000 
(0.0000) 
1.7632 
(0.5787) 
0.0000 
(0.0000) 
0.0526 
(0.0367) 
0.1053 
(0.0505) 
0.0000 
(0.0000) 
0.0000  
(0.0000) 
R 1.1351 
(0.1004) 
0.4234 
(0.0608) 
0.2793 
(0.0560) 
0.0090 
(0.0090) 
0.1712 
(0.0477) 
0.0991 
(0.0338) 
0.0000 
(0.0000) 
1.2162 
(0.2989) 
0.1802 
(0.0465) 
0.0180 
(0.0127) 
0.0811 
(0.0290) 
0.0631 
(0.0547) 
0.0090  
(0.0090) 
S 0.9672 
(0.0809) 
1.3770 
(0.5090) 
0.0984 
(0.0385) 
0.0000 
(0.0000) 
0.0984 
(0.0385) 
0.0492 
(0.0279) 
0.1311 
(0.1312) 
0.6230 
(0.3585) 
0.0164 
(0.0164) 
0.0164 
(0.0164) 
0.0656 
(0.0396) 
0.4426 
(0.3685) 
0.0164  
(0.0164) 
T 1.0000 
(0.0756) 
1.1400 
(0.2374) 
0.0000 
(0.0000) 
0.1000 
(0.0429) 
0.3000 
(0.0714) 
0.1400 
(0.0640) 
0.0000 
(0.0000) 
4.5600 
(0.5556) 
0.0200 
(0.0200) 
0.0200 
(0.0200) 
0.0600 
(0.0339) 
0.0000 
(0.0000) 
0.0200  
(0.0200) 
U 0.7333 
(0.1817) 
0.5333 
(0.1652) 
0.2000 
(0.1069) 
0.0000 
(0.0000) 
0.2667 
(0.1182) 
0.7333 
(0.5387) 
0.0000 
(0.0000) 
2.4667 
(0.5845) 
0.2000 
(0.1069) 
0.1333 
(0.0909) 
0.1333 
(0.0909) 
0.0000 
(0.0000) 
0.1333  
(0.1333) 
W 1.1667 
(0.1667) 
0.1667 
(0.1667) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.1667 
(0.1667) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.1667 
(0.1667) 
0.0000 
(0.0000) 
0.1667  
(0.1667) 
X 1.0000 
(0.1000) 
0.3200 
(0.1800) 
0.0400 
(0.0400) 
0.0000 
(0.0000) 
0.2000 
(0.1000) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
1.1200 
(0.4333) 
0.6000 
(0.1732) 
0.2000 
(0.0817) 
0.2400 
(0.1046) 
0.0000 
(0.0000) 
0.0400  
(0.0400) 
Y 1.2222 
(0.1470) 
0.3333 
(0.2357) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.1111 
(0.1111) 
0.3333 
(0.3333) 
0.0000 
(0.0000) 
0.6667 
(0.1667) 
0.1111 
(0.1111) 
0.0000 
(0.0000) 
0.1111 
(0.1111) 
0.0000 
(0.0000) 
0.0000  
(0.0000) 
Z 1.0000 
(0.2582) 
0.3333 
(0.3333) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.1667 
(0.1667) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.0000 
(0.0000) 
0.1667 
(0.1667) 
0.0000 
(0.0000) 
0.0000  
(0.0000) 
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All 1.1155 
(0.0315) 
0.5817 
(0.0620) 
0.1474 
(0.0177) 
0.1076 
(0.0252) 
0.2948 
(0.0245) 
0.1408 
(0.0292) 
0.0452 
(0.0236) 
2.1527 
(0.1503) 
0.1873 
(0.0196) 
0.0598 
(0.0090) 
0.1089 
(0.0125) 
0.1474 
(0.0662) 
0.0239  
(0.0067) 
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Figure 1. 
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Figure 2. 
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Supplementary Appendix I. The unit costs were based on the official Finnish 
Pirkanmaa health districta, Tampere health centre, Hatanpää hospital and Tampere 
Imagingb, Fimlab laboratoryc list prices (tariffs) from year 2013, and “Unit costs of 
health care in Finland 2006” by Hujanen et al. (2008)d which were transformed to 2013 
real values using the official health care price index for public services obtained from 
Statistics Finlande. If more than one unit cost was used in the resource valuation, range 
(lowest unit cost-highest unit cost), arithmetic mean,  median {50th percentile}, and 
mode [unit cots that appeared most often in the data] were given. 
 
Resource 
Unit costs (€ 2013). If several different unit costs 
were used, range, mean {median} [mode] were given 
Visits  
Doctor 118.46b 
Doctor on-call 118.46b 
Nurse 38.64b 
Physiotherapist 88.42b 
Dietician 108.36b 
Pedicure 38.64b 
Mental nurse 116.02b 
Calls  
Doctor 20.69d, e 
Nurse 9.14d, e 
One day at Ward in PHC 262.30b 
Laboratory service charge 11.90c 
Basic laboratory test 1.55c 
Special laboratory test 1 2.60-95.00c, 28.05 {20.50} [18.50] 
Imaging  
X-ray 40.08b 
Ultrasound 94.26-161.50b, 101.41 {94.26} [94.26] 
Magnetic resonance imaging 277.65-277.80b, 277.69 {277.69} [277.65] 
Scopy 195.00-280.67a, b, 246.08 {280.67} [280.67] 
Special examination 45.00-280.00a, 120.87 {111.97} [52.00] 
SHC outpatient clinic2 67.00-1402.00a, 291.58 {233.00} [89.00] 
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SHC outpatient clinic on-call2 189.00-1350.00a, 472.08 {444.00} [450.00] 
Specialized doctor visit3 42.50-153.00b, 70.82 {57.50} [57.50] 
One day at Ward in SHC 
306.00-1330.00a, 644.58 {593.60} [306.00, multiple 
modes exist, the smallest value is shown] 
Procedure in SHC 274.00-31,775.00a, 888.67 {1133.00} [1133.00] 
Special material in SHC4 370.00a 
PHC = primary health care. SHC = secondary (specialist) health care.  
1Exact prices were calculated for laboratory tests that differed much from the cost of basic blood count, 
which was used as a price estimate for a basic laboratory test. Classification was retrospectively done by 
two researcher physicians. Special laboratory tests include for example Pap smear, bacterial culture from 
wound, urine or sputum, urine drug screen, bone marrow aspiration, antibodies, glucose and lactose 
intolerance test and white blood cell count. 
2Secondary health care outpatient clinic and clinic on-call refer to policlinics of different specialties at the 
central hospital or at the city hospital at the public sector. 
3Visit at a specialized doctor refer to visits at the private sector with payment commitment or voucher. 
4In one SHC procedure special material was used which was added to the total cost of that episode of 
care. 
 
Sources 
a. Personal communication by Leila Matikka, Pirkanmaa Hospital District 
b. Personal communications by chief physicians Kati Myllymäki, Erkki Lehtomäki and 
Pirkko Ranki 
c. Personal communication by Maria Helenius, Fimlab Laboratories Ltd. 
d. Hujanen T, Kapiainen S, Tuominen U, Pekurinen M. Terveydenhuollon 
yksikkökustannukset Suomessa vuonna 2006. Helsinki: Stakes. 
e. Suomen virallinen tilasto (SVT): Julkisten menojen hintaindeksi [verkkojulkaisu]. 
ISSN=1798-4505. Helsinki: Tilastokeskus.
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Supplementary Appendix II. The mean total and primary care costs and their 95% confidence intervals (CI = confidence interval, LL = lower limit, 
UL = upper limit, PC = primary care). 
ICPC-2 
chapter 
Mean cost 
(2013 euro) 
95%CI 
LL 
95%CI 
UL 
Boostrapped 
CI LL 
Bootstrapped 
CI UL 
Mean PC cost 
(2013 euro) 
95%CI 
PC, LL 
95%CI 
PC, UL 
n 
A 484.10 -106.86 1075.05 -94.89 1063.08 261.91 94.86 428.97 53 
B 232.80 141.60 232.99 148.24 317.35 214.20 117.74 310.66 10 
D 302.58 218.30 386.85 219.22 385.94 249.93 196.77 303.09 48 
F 177.98 142.56 213.41 143.46 212.51 162.38 131.47 193.30 15 
H 236.57 162.65 310.48 163.81 309.33 174.87 133.16 216.58 45 
K 909.85 142.60 1677.11 154.07 1665.64 257.12 195.24 319.00 104 
L 311.85 260.92 362.78 263.43 360.26 271.08 230.15 312.01 130 
N 278.75 174.71 382.80 176.74 380.77 258.20 164.00 352.40 27 
P 332.31 259.15 405.48 259.44 405.19 306.05 238.24 373.87 38 
R 262.08 197.03 327.12 196.79 327.36 217.11 186.41 247.80 111 
S 429.18 37.48 820.87 29.97 828.39 230.87 126.08 335.65 61 
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T 212.76 179.95 245.58 180.12 245.41 198.84 172.70 225.00 50 
U 414.32 15.48 813.16 29.58 799.06 209.99 145.75 274.23 15 
W 176.59 110.43 242.75 115.96 237.22 148.09 81.99 214.20 6 
X 237.66 184.12 291.21 185.63 289.70 203.80 164.53 243.08 25 
Y 191.75 148.61 234.88 150.34 233.15 182.86 144.03 221.69 9 
Z 223.62 42.29 404.95 59.57 387.67 134.79 78.16 191.41 6 
 
 
 
